Double Blinded Randomized Trial Between Lidocaine And Plain Gel For Urethral Straight Catheterization And The Q-Tip Test
1 other identifier
interventional
137
1 country
1
Brief Summary
The purpose of this study is to compare the pain perception between lidocaine and plain aqueous gel during assessment of postvoid residual volume and the Q-tip test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for phase_4 pain
Started Nov 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
November 1, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
September 1, 2008
CompletedFirst Submitted
Initial submission to the registry
April 15, 2009
CompletedFirst Posted
Study publicly available on registry
April 17, 2009
CompletedResults Posted
Study results publicly available
September 13, 2011
CompletedSeptember 13, 2011
August 1, 2011
10 months
April 15, 2009
July 18, 2011
August 10, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Patient's Perception of Pain Using the Wong-Baker FACES Visual Scale: 0 - no Pain; 5 - Worst Imaginable Pain
A sterile catheter lubricated with the allocated gel was placed transurethrally into the bladder to measure the postvoid residual volume. After removal of the catheter, a cotton swab, coated with the same allocated gel, was advanced to the urethrovesical junction until resistance was felt. The angle of the swab with the horizontal plane was measured at rest and with a Valsalva maneuver. Immediately following the Q-tip test, the patient's perception of pain level was measured by Wong-Baker FACES Pain Scale, a visual scale where 0 represents no pain and 5 represents worst imaginable pain.
Immediately after the examination
Study Arms (2)
Lidocaine
ACTIVE COMPARATOR2% Lidocaine jelly will be applied onto the catheter and then the cotton swab during evaluation of postvoid residual and the Q-tip test.
Aqueous gel
PLACEBO COMPARATORPlain aqueous gel as placebo will be applied onto the catheter and then the cotton swab during evaluation of postvoid residual and the Q-tip test.
Interventions
2% Lidocaine jelly will be applied onto the catheter and then the cotton swab during evaluation of postvoid residual and the Q-tip test.
Plain aqueous gel will be applied onto the catheter and then the cotton swab during evaluation of postvoid residual and the Q-tip test.
Eligibility Criteria
You may qualify if:
- All women who presented to a single urogynecologist's office for an initial consultation with a complaint of urinary incontinence and/or pelvic organ prolapse
You may not qualify if:
- Being a minor
- Pregnancy
- Allergy to Lidocaine or aqueous lubricant gel
- Any current use of analgesia
- Structural abnormalities of the urethra
- Active genital Herpes or other vulvovaginal infections or inability to cooperate with pain assessment due to mental disorders.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Baystate Medical Center
Springfield, Massachusetts, 01199, United States
Related Publications (1)
Harmanli OH, Okafor O, Ayaz R, Knee A. Lidocaine jelly and plain aqueous gel for urethral straight catheterization and the Q-tip test: a randomized controlled trial. Obstet Gynecol. 2009 Sep;114(3):547-550. doi: 10.1097/AOG.0b013e3181b43808.
PMID: 19701033RESULT
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Oz Harmanli, MD
- Organization
- Baystate Medical Center
Study Officials
- PRINCIPAL INVESTIGATOR
Oz Harmanli, MD
Baystate Medical Center
Publication Agreements
- PI is Sponsor Employee
- Yes
Study Design
- Study Type
- interventional
- Phase
- phase 4
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
April 15, 2009
First Posted
April 17, 2009
Study Start
November 1, 2007
Primary Completion
September 1, 2008
Study Completion
September 1, 2008
Last Updated
September 13, 2011
Results First Posted
September 13, 2011
Record last verified: 2011-08